Status:
COMPLETED
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Bladder Cancer
Transitional Cell Carcinoma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to to find out if the MRI and PET scans can truly stage patients with bladder cancer. Both scans use newer ways to find out if your disease has grown beyond the bladder. T...
Eligibility Criteria
Inclusion
- Thirty (30) patients will be enrolled in this pilot study.
- All patients will have a clinical or histologic diagnosis of bladder cancer with active disease identified within the bladder at the time of consent and imaging.
- Patients with primary resectable lesions, and localized or regionally extensive disease will be eligible with residual disease in the bladder at the time of imaging.
- All patients will have consented to treatment at MSKCC
Exclusion
- Prior pelvic radiation for bladder cancer
- Non-transitional cell histologies
- Patients deemed not appropriate surgical candidates
- Patients that are pregnant or lactating
- Patients that cannot tolerate being in the PET or MRI scanner for the duration of the study. Patients deemed unable to receive a contrast enhance CT will remain eligible.
- Vulnerable patients (minors, mentally retarded, prisoners, etc.)
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00612326
Start Date
June 1 2004
End Date
March 1 2008
Last Update
December 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065